Variable | Univariate analysis | Multivariate analysis | ||
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Age | 1.1010 (0.994 - 1.026) | 0.226 |
|
|
Gender (M) | 2.237 (1.558 - 3.211) | <0.001 | 0.02 (0.005 - 0.299) | 0.02 |
BP-History | 0.693 (0.491 - 0.978) | 0.037 | 0.025 (0.03 - 0.220) | 0.04 |
Antihypertensive medication history | 0.674 (0.477 - 0.954) | 0.026 |
|
|
Type 2 diabetes* | 0.51 (0.31 - 0.83) | 0.07 |
|
|
Diabetes Medication | 0.476 (0.287 - 0.789) | 0.04 |
|
|
Smoking | 0.307 (0.205 - 0.461) | <0.01 | 0.061 (0.08 - 0.441) | 0.06 |
Leukocyte, 109/L* | 1.308 (1.203 - 1.422) | <0.01 |
|
|
Monocytes, 109/L* | 3.305 (1.591 - 6.868) | 0.01 |
|
|
Neutrophils, 109/L* | 1.499 (1.439 - 1.665) | <0.01 |
|
|
Hemoglobin, g/L* | 1.014 (1.003 - 1.028) | 0.016 |
|
|
Glycated hemoglobin, %* | 1.313 (1.128 - 1.529) | <0.001 |
|
|
AST, U/L* | 1.029 (1.017 - 1.040) | <0.001 |
|
|
Glomerular filtration rate, ml/min | 0.987 (0.977 - 0.998) | 0.018 | 0.948 (0.930 - 0.995) | 0.017 |
TC, mmol/L | 1.284 (1.090 - 1.512) | 0.03 |
|
|
HDL-C, mmol/L | 0.329 (0.175 - 0.619) | <0.01 |
|
|
LDL-C, mmol/L | 1.563 (1.289 - 1.895) | <0.01 |
|
|
TG, mmol/L | 1.178 (1.000 - 1.387) | 0.05 |
|
|
ApoB, g/L | 2.282 (1.311 - 3.971) | 0.04 |
|
|
LP (a), g/L | 3.910 (1.663 - 9.192) | 0.02 |
|
|
LVEF, % | 0.889 (0.857 - 0.922) | <0.01 |
|
|
non-proBNP, pg/ml | 1.006 (1.004 - 1.008) | <0.01 |
|
|
ADAMTS-9 | 1.959 (1.647 - 2.327) | <0.01 | 2.941 (1.932 - 4.477) | 0.001 |